Near future
No Result
View All Result
October 2, 2023
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Transports
  • Spazio
  • AI
  • concepts
  • H+
Understand, anticipate, improve the future.
CES2023 / Coronavirus / Russia-Ukraine
Near future
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Transports
  • Spazio
  • AI
  • concepts
  • H+

Understand, anticipate, improve the future.

No Result
View All Result
Technology

Asthma, a mix of drugs reduces attacks by 24%. Researchers: It's a paradigm shift

The new drug mix works asthma in the hips, improving lung function, reducing attacks and mitigating flare-ups.

May 28, 2022
Gianluca RiccioGianluca Riccio
⚪ 3 minutes
Share36Pin10Tweet23SendShare6ShareShare5
Asthma

READ IN:

Asthma affects between 100 and 150 million people worldwide. Today a clinical study shows that using a new combination of two drugs significantly reduced their chances of suffering an acute attack.

Participants in the study, published in the New England Journal of Medicinereceived a mix of two drugs via inhaler. One, albuterol, relaxes smooth muscle and is used to relieve acute asthma. The other, budesonide, is a corticosteroid. Together, the two drugs reduced unexpected episodes of wheezing, wheezing and coughing - things you don't mess around with, which sometimes lead to hospital, or in more rare cases to death.

Asthma

A paradigm shift

“This cure is a paradigm shift in asthma treatment. We look forward to this first of its kind combination treatment becoming part of standard therapy ", says author Reynold Panettieri Jr. , professor of medicine at Rutgers Robert Wood Johnson Medical School.

The Mandala Phase 3 clinical trial, which involved more than 3.000 asthma patients at 295 sites in the United States, Europe and South America, evaluated the safety and efficacy of a mix of salbuterol and budesonide as a therapy for people with mild to severe asthma.

The article continues after the related links

LK-99, new episode: is it really superconductive at room temperature?

Comment la CVP Impack Machine de Sparck Technologies peut Revolutionner l'Industrie de l'Emballage

It is an evolution of several standard treatments, which involve a "rescue" medicine such as salbuterol via the inhaler, and subsequently doses of oral steroids (less frequently, due to the strong side effects). This mix brings together the benefits while mitigating the inconveniences.

The Asthma Treatment Study

Patients were divided into three groups: two received the mix of the two drugs in different dosages, one third received a placebo. Results? Patients who received the drug improved their lung function and experienced fewer attacks.

Scientists have found that salbuterol with the highest dose of budesonide reduces the risk of an asthma attack 27% in the short term e 24% per year. This combination has also reduced 33% use of corticosteroids.

In other words, this new inhaler delivers what you need, when you need it and in the right dose, while also protecting you from flare-ups.

A good breath of air, it must be said.

Latest news

  • LK-99, new episode: is it really superconductive at room temperature?
  • Comment la CVP Impack Machine de Sparck Technologies peut Revolutionner l'Industrie de l'Emballage
  • Nobel Prize for Medicine to the creators of the mRNA techniques behind the Covid vaccines
  • SciMatch: take a selfie and meet your soulmate
  • The future glucose monitoring? A new, ingenious sweat sensor
  • From death to passion: if spider venom overcomes erectile dysfunction
  • Getting old? No, thanks: the future of longevity between research and speculation
  • Videogames and photorealism: increasingly thin border between game and reality
  • This is how a war between humans and artificial intelligence would end
  • The alarm of Japanese scientists: microplastics also in the clouds


GPT Chat Megaeasy!

Concrete guide for those approaching this artificial intelligence tool, also designed for the school world: many examples of applications, usage indications and ready-to-use instructions for training and interrogating Chat GPT.

To submit articles, disclose the results of a research or scientific discoveries write to the editorial staff

Enter the Telegram channel of Futuroprossimo, click here. Or follow us on Instagram, Facebook, Twitter, Mastodon e LinkedIn.

FacebookTwitterInstagramTelegramLinkedInMastodonPinterestTikTok

The daily tomorrow.


Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.

  • Environment
  • Architecture
  • Artificial intelligence
  • Gadgets
  • concepts
  • Design
  • Medicine
  • Spazio
  • Robotica
  • Work
  • Transports
  • Energy
  • Edition Francaise
  • Deutsche Ausgabe
  • Japanese version
  • English Edition
  • Portuguese Edition
  • Read more
  • Spanish edition

Subscribe to our newsletter

  • The Editor
  • Advertising on FP
  • Privacy Policy

© 2023 Near future - Creative Commons License
This work is distributed under license Creative Commons Attribution 4.0 International.

No Result
View All Result
Understand, anticipate, improve the future.
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Transports
  • Spazio
  • AI
  • concepts
  • H+